Press release from Companies: WntResearch announces Foxy-5 is safe and well tolerated and qualifies for next dose level

Press release from Companies: WntResearch announces Foxy-5 is safe and well tolerated and qualifies for next dose level

Press release from Companies: WntResearch announces Foxy-5 is safe and well tolerated and qualifies for next dose level

Press release from Companies: WntR meddelar att Foxy-5 visat sig vara säker och väl tolererad och därför kan fortsätta till nästa dos nivå

Press release from Companies: WntR meddelar att Foxy-5 visat sig vara säker och väl tolererad och därför kan fortsätta till nästa dos nivå

Press release from Companies: WntResearch has now received a US Patent for its Lead Cancer Compound Foxy-5

Press release from Companies: WntResearch has now received a US Patent for its Lead Cancer Compound Foxy-5

Press release from Companies: WntResearch has now received a US Patent for its Lead Cancer Compound Foxy-5

Press release from Companies: WntResearch har nu erhållit ett patent för sin ledande anti-metastatiska peptid produkt Foxy-5 i USA

Press release from Companies: WntResearch har nu erhållit ett patent för sin ledande anti-metastatiska peptid produkt Foxy-5 i USA

Press release from Companies: WntResearch har nu erhållit ett patent för sin ledande anti-metastatiska peptid produkt Foxy-5 i USA

Press release from Companies: WntResearch has now received a US Patent for its Lead Cancer Compound Foxy-5